Cell Therapy Research
Dec
Alnylam Presents New Data on Delivery of RNAi Therapeutics and Human Translation
Alnylam Presents New Data on Delivery of RNAi Therapeutics and Human Translation Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, presented new data at the 2010 International Chemical Congress of Pacific Basin Societies , being held in Honolulu, Hawaii, December 15-20. Read more on Business Wire via Yahoo! Finance
Dec
Berlin Breakthrough Brings New Hope to AIDS Patients
Berlin Breakthrough Brings New Hope to AIDS Patients There is an incredible medical breakthrough being reported in the fight against AIDS and HIV. Doctors in Berlin an HIV-positive man who underwent a stem cell transplant is now cured as a… Read more on NBC Bay Area
Dec
Single quantum dot nanowire photodetectors
Single quantum dot nanowire photodetectors Moving a step closer toward quantum computing, a research team in the Netherlands recently fabricated a photodetector based on a single nanowire, in which the active element is a single quantum dot with a volume of a mere 7,000 cubic nanometers. The device is described in the American Institute of [...]
Dec
‘Fountain of youth’ pill could restore aging immune system
‘Fountain of youth’ pill could restore aging immune system SAN FRANCISCO — UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age. Read more on UC Newsroom
Dec
Stem Cell Treatment Is Effective for Certain Cases of Acute Leukemia
Stem Cell Treatment Is Effective for Certain Cases of Acute Leukemia Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies. Read more on Newswise
Dec
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer WOBURN, Mass.–(BUSINESS WIRE)–BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that a Phase 3 pivotal study with OncoVEXGM-CSF for the first line treatment of patients with locally advanced squamous cell carcinoma of [...]
Dec
When sex wouldn’t stop hurting
When sex wouldn’t stop hurting For years, I gritted my teeth through life’s most “pleasurable” experience. And it’s more common than you may think Read more on Salon.com
Dec
Emerald BioStructures Leads International Consortium to Crystallize Key Parkinson’s Disease Enzyme
Emerald BioStructures Leads International Consortium to Crystallize Key Parkinson’s Disease Enzyme BAINBRIDGE ISLAND, Wash.–(BUSINESS WIRE)–Emerald BioStructures, a leading provider of integrated structural biology services, has received funding from The Michael J. Fox Foundation for Parkinson’s Research. Read more on Business Wire
Dec
Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation …
Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation … CRANBURY, N.J., Dec. 8, 2010 /PRNewswire/ — Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company focused on developing treatments for rare diseases, today announced that it has been awarded a second grant from The Michael J. Fox Foundation for Parkinson’s [...]
Dec
IP Update
IP Update The invention, the patent’s abstract states, comprises “methods and vectors and kits … for producing chimeric nucleic acid constructs capable of producing dsRNA for silencing target nucleic acid sequences of interest using recombinational cloning.” Read more on GenomeWeb News